久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

美國 Seahorse Bioscience
美國 Seahorse Bioscience 利用細胞外流量（Extracellular Flux，XF）檢測專利技術，發明了業界第一款細胞能量代謝實時測定儀：XF96。

Asia/Pacific Headquarters
Shanghai, China

0086 21 33901768

Serving the life sciences industry since 2001, Seahorse Bioscience provides industry-leading analytical instruments, biomanufacturing systems and consumable labware products for biological research and drug discovery. Our customers include scientists at academic institutions, pharmaceutical and biotech organizations, as well as OEM manufacturers of assay kits and lab instruments suppliers.

Novel XF Instrument Technology

Transient Microchamber

Transient MicrochamberIntroduced in 2006, our extracellular flux technology combines a sophisticated electro-optical instrument with "smart plastic" cartridges to enable the real-time measurement of cellular bioenergetics in a non-invasive, multi-well microplate format.

Utilized by scientists around the world, the measurement of extracellular flux plays an important role in the drug discovery and development process. The XF Series of extracellular flux analyzers has become the worldwide standard for mitochondrial dysfunction and for performing quality control pre-screens for all cell-based assays.

Innovative Microplate Development

Since 1984, our labware manufacturing group (formerly Innovative Microplate) has designed and produced more molds for microplates than any other company in the world. OEM assay kit manufacturers, instrument suppliers, and end users rely on our expertise in designing and manufacturing sophisticated, high-quality molded consumables on time and at reasonable costs.

Our customers are innovators that want to explore challenging design concepts that must interact with new hardware, reagents or biology. By offering design, tooling, molding, testing and assembly steps under one roof, we are able to iterate designs quickly and at low cost. Our customers appreciate our ability to work with them to optimize challenging new designs and our willingness to accommodate the ramp of production volumes as new products are introduced and gain traction.
?